Identification of a CD11b+/Gr-1+/CD31+ myeloid progenitor capable of activating or suppressing CD8+ T cells

Blood

Volumn 96, Issue 12, 2000, Pages 3838-3846

  Bronte, V ^a   Apolloni, E ^a   Cabrelle, A ^a   Ronca, R ^a   Serafini, P ^a   Zamboni, P ^a   Restifo, N P ^a   Zanovello, P ^a  

^a Dept of Oncol/Surgical Sciences ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD31 ANTIGEN; CD8 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; VIRUS VACCINE;

ANIMAL CELL; ANTIGEN DETECTION; APOPTOSIS; ARTICLE; CELL CULTURE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; SPLEEN; T LYMPHOCYTE ACTIVATION; TUMOR GROWTH;

EID: 0034551670     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.12.3838.h8003838_3838_3846     Document Type: Article

References (44)

1. Antigen-presenting cells for unprimed T cells
2. Dendritic cells and the control of immunity
3. Costimulatory regulation of T cell function
4. Mature T lymphocyte apoptosis - Immune regulation in a dynamic and unpredictable antigenic environment
5. Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation
6. Apoptotic death of CD8+ T lymphocytes after immunization: Induction of a suppressive population of Mac-1 +/Gr-1 + cells
7. The expanding universe of T-cell subsets: Th1, Th2 and more
8. Macrophage activation by T cells
9. Other functions, other genes: Alternative activation of antigen-presenting cells
10. Interleukin 4 potently enhances murine macrophage mannose receptor activity: A marker of alternative immunologic macrophage activation
11. Membrane molecules as differentiation antigens of murine macrophages
12. Vaccinia virus expression vector: Coexpression of beta-galactosidase provides visual screening of recombinant virus plaques
13. Expression of proteins in mammalian cells using vaccinia viral vectors
14. Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen
15. IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases
16. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes
17. Markers of mouse macrophage development detected by monoclonal antibodies
18. Distinct mouse bone marrow macrophage precursors identified by differential expression of ER-MP12 and ER-MP20 antigens
19. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis
20. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
21. Proliferating dendritic cell progenitors in human blood
22. Generation and functional characterization of mouse monocyte-derived dendritic cells
23. Nitric oxide-producing CD11b(+)Ly-6G(Gr-1)(+)CD31(ER-MP12)(+) cells in the spleen of cyclophosphamide-treated mice: Implications for T-cell responses in immunosuppressed mice
24. High-level expression of the ER-MP58 antigen on mouse bone marrow hematopoietic progenitor cells marks commitment to the myeloid lineage
25. Bone marrow cellular composition in Listeria monocytogenes infected mice detected using ER-MP12 and ER-MP20 antibodies: A flow cytometric alternative to differential counting
26. Interleukin-13 alters the activation state of murine macrophages in vitro: Comparison with interleukin-4 and interferon-gamma
27. Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells
28. Differential induction of prostaglandin E2-dependent and -independent immune suppressor cells by tumor-derived GM-CSF and M- CSF
29. The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma: I, induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF
30. Mechanisms of tumor-induced immunosuppression: Evidence for contact-dependent T cell suppression by monocytes
31. Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide
32. Sca1(+)/Mac1(+) nitric oxide-producing cells in the spleens of recipients early following bone marrow transplant suppress T cell responses in vitro
33. Wheat germ agglutinin-positive cells in a stem cell-enriched fraction of mouse bone marrow have potent natural suppressor activity
34. Heterogeneity of splenic natural suppressor cells induced in mice by treatment with cyclophosphamide
35. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo
36. Dramatic numerical increase of functionally mature dendritic cells in FLT3 ligand-treated mice
37. Developmental pathways of dendritic cells in vivo: Distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice
38. Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but not CD11b(low)CD11c(high) murine dendritic cells in vivo: A comparative analysis with Flt3 ligand
39. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo
40. Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cells
41. Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells
42. Human prostate carcinoma cell lines secrete GM-CSF and express GM-CSF-receptor on their cell surface
43. Secretion of bioactive granulocyte-macrophage colony-stimulating factor by human colorectal carcinoma cells
44. Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection